AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24949654 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily insulin glulisine initiated at a fifth (20%) the dose of insulin glargine
Number of subjects: 62
Study 24949654 — intervention group
Group type: COMPARATOR
Intervention: Maximized dose of sitagliptin to 100 mg
Number of subjects: 62
Study 23185923 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal neostigmine 25 microg combined with 0.5% hyperbaric bupivacaine 15 mg and fentanyl 25 microg
Number of subjects: 60
Study 23185923 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.5 ml) combined with 0.5% hyperbaric bupivacaine 15 mg and fentanyl 25 microg
Number of subjects: 60
Study 20354436 — intervention group
Group type: EXPERIMENTAL
Intervention: Sheep sound played during anesthesia
Number of subjects: 300
Study 20354436 — intervention group
Group type: COMPARATOR
Intervention: White noise played during anesthesia
Number of subjects: 300
Study 18176737 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcranial magnetic stimulation
Number of subjects: 9
Study 18176737 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial magnetic stimulation
Number of subjects: 9
Study 15923431 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI regimen (Irinotecan 180 mg/m² on day 1 with LV5FU2 regimen)
Number of subjects: 287
Study 12842840 — intervention group
Group type: EXPERIMENTAL
Intervention: +1444TT homozygotes
Number of subjects: 443
Study 12842840 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG patients +1444TT homozygotes
Number of subjects: 443
Study 12842840 — intervention group
Group type: COMPARATOR
Intervention: CABG patients
Number of subjects: 443
Study 10832123 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (rt-PA 50 mg, 10 mg as a bolus plus 40 mg in 60 min)
Number of subjects: 90
Study 10832123 — intervention group
Group type: COMPARATOR
Intervention: Group B (conventional therapy)
Number of subjects: 90
Study 10832123 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 90
Study 10832123 — intervention group
Group type: COMPARATOR
Intervention: Group B
Number of subjects: 90
Study 8889351 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic-based screening
Number of subjects: 94
Study 8889351 — intervention group
Group type: COMPARATOR
Intervention: Mass mailing campaigns
Number of subjects: 94
Study 8889351 — intervention group
Group type: COMPARATOR
Intervention: Mass media campaigns
Number of subjects: 94
Study 8889351 — intervention group
Group type: COMPARATOR
Intervention: Referrals by patients with end-stage renal disease
Number of subjects: 94
Study 8889351 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-based randomization yields
Number of subjects: 94
Study 8889351 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prescreening
Number of subjects: 94
Study 8889351 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender distribution
Number of subjects: 94
Study 1639462 — intervention group
Group type: EXPERIMENTAL
Intervention: captopril (25 mg b.i.d.) for 4 days
Number of subjects: 46
Study 1639462 — intervention group
Group type: COMPARATOR
Intervention: placebo for 4 days
Number of subjects: 46
Study 6436868 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid 1 g
Number of subjects: 6
Study 6436868 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid 2 g
Number of subjects: 6
Study 6436868 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid 4 g
Number of subjects: 6
Study 6436868 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 5 mg (Control)
Number of subjects: 6
Study 31117149 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture plus on-demand gastrocaine
Number of subjects: 132
Study 31117149 — intervention group
Group type: COMPARATOR
Intervention: On-demand gastrocaine alone
Number of subjects: 132
Study 28341106 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib
Number of subjects: 0
Study 28341106 — intervention group
Group type: COMPARATOR
Intervention: Gefitinib
Number of subjects: 0
Study 25500787 — intervention group
Group type: EXPERIMENTAL
Intervention: MINT (phone-delivered Motivational Interviewing)
Number of subjects: 452
Study 25500787 — intervention group
Group type: COMPARATOR
Intervention: DVD (educational video)
Number of subjects: 452
Study 23039373 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume guaranteed (VG) ventilation
Number of subjects: 72
Study 23039373 — intervention group
Group type: COMPARATOR
Intervention: Conventional SIMV
Number of subjects: 72
Study 20694577 — intervention group
Group type: EXPERIMENTAL
Intervention: Good Behavior Game (GBG) intervention
Number of subjects: 433
Study 20694577 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 433
Study 19337944 — intervention group
Group type: EXPERIMENTAL
Intervention: Juvederm ULTRA 3
Number of subjects: 126
Study 19337944 — intervention group
Group type: COMPARATOR
Intervention: Restylane-Perlane
Number of subjects: 126
Study 16456368 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram protocol
Number of subjects: 153
Study 16456368 — intervention group
Group type: COMPARATOR
Intervention: Chart protocol
Number of subjects: 153
Study 15297583 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine artery embolization (UAE)
Number of subjects: 99
Study 11736725 — intervention group
Group type: EXPERIMENTAL
Intervention: Helicobacter pylori eradication treatment
Number of subjects: 0
Study 11736725 — intervention group
Group type: COMPARATOR
Intervention: Ulcer healing treatment followed by maintenance therapy
Number of subjects: 0
Study 9622911 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid articulation process
Number of subjects: 0
Study 9622911 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrieval of words from short-term memory
Number of subjects: 0
Study 9622911 — intervention group
Group type: EXPERIMENTAL
Intervention: Profile of processing rates in the brain
Number of subjects: 0
Study 9622911 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related processing rates
Number of subjects: 0
Study 7909049 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral slow-release theophylline, 200 mg 12 hourly
Number of subjects: 19
Study 2885367 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaspirone
Number of subjects: 9
Study 2885367 — intervention group
Group type: COMPARATOR
Intervention: Standard neuroleptics
Number of subjects: 9
Study 30238557 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 5000 IU/day
Number of subjects: 65
Study 30238557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 28042649 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (selenomethionine 83 mcg/day for four months)
Number of subjects: 192
Study 28042649 — intervention group
Group type: COMPARATOR
Intervention: Control group (no selenium supplementation)
Number of subjects: 192
Study 26121696 — intervention group
Group type: EXPERIMENTAL
Intervention: HEBI
Number of subjects: 160
Study 26121696 — intervention group
Group type: EXPERIMENTAL
Intervention: Plumpy'Nut
Number of subjects: 160
Study 26121696 — intervention group
Group type: COMPARATOR
Intervention: Control (no RUTF)
Number of subjects: 160
Study 25220321 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal stenting
Number of subjects: 0
Study 25220321 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 22147129 — intervention group
Group type: EXPERIMENTAL
Intervention: Band Ligation (BL), n = 20
Number of subjects: 58
Study 22147129 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate (CY), n = 18
Number of subjects: 58
Study 22147129 — intervention group
Group type: COMPARATOR
Intervention: Control group (diagnostic endoscopy), n = 20
Number of subjects: 58
Study 19321012 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of single lens glasses, with counselling and advice about appropriate use
Number of subjects: 580
Study 19321012 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 580
Study 16849403 — intervention group
Group type: EXPERIMENTAL
Intervention: NBI-42902 (5 mg)
Number of subjects: 56
Study 16849403 — intervention group
Group type: EXPERIMENTAL
Intervention: NBI-42902 (150 mg)
Number of subjects: 56
Study 16849403 — intervention group
Group type: EXPERIMENTAL
Intervention: NBI-42902
Number of subjects: 56
Study 12570823 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocytapheresis (LCAP) weekly for 5 weeks, then once every 4 weeks as maintenance therapy
Number of subjects: 76
Study 12570823 — intervention group
Group type: COMPARATOR
Intervention: High dose prednisolone (h-PSL) 30-40 mg/day for moderately severe and 60-80 mg/day for severe patients, then gradually tapered
Number of subjects: 76
Study 10863913 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D vision
Number of subjects: 3
Study 10863913 — intervention group
Group type: COMPARATOR
Intervention: 2-D vision
Number of subjects: 3
Study 9090733 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive community treatment only
Number of subjects: 165
Study 9090733 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive community treatment with community workers
Number of subjects: 165
Study 9090733 — intervention group
Group type: COMPARATOR
Intervention: Broker case management
Number of subjects: 165
Study 8477962 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (13 to 15 mg daily)
Number of subjects: 33
Study 8477962 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 3549909 — intervention group
Group type: EXPERIMENTAL
Intervention: Rowatinex
Number of subjects: 40
Study 3549909 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 28621011 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (8 weekly 75-min classes)
Number of subjects: 26
Study 28621011 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 26
Study 28621011 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 26
Study 27085288 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT)
Number of subjects: 30
Study 27085288 — intervention group
Group type: COMPARATOR
Intervention: Control (no LLLT)
Number of subjects: 30
Study 24958663 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin norm condition
Number of subjects: 146
Study 24958663 — intervention group
Group type: COMPARATOR
Intervention: Heavy norm condition
Number of subjects: 146
Study 22825942 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥ 25 kg/m(2)
Number of subjects: 131
Study 22825942 — intervention group
Group type: COMPARATOR
Intervention: BMI < 25 kg/m(2)
Number of subjects: 131
Study 20526599 — intervention group
Group type: EXPERIMENTAL
Intervention: Alvimopan
Number of subjects: 0
Study 20526599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18388765 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT-BN)
Number of subjects: 80
Study 18388765 — intervention group
Group type: COMPARATOR
Intervention: Individual supportive psychotherapy
Number of subjects: 80
Study 16497254 — intervention group
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA)
Number of subjects: 17
Study 16497254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 12559536 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone and verapamil 240 mg/day (group VER)
Number of subjects: 21
Study 12559536 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone and metoprolol 100 mg/day (group MET)
Number of subjects: 21
Study 12559536 — intervention group
Group type: EXPERIMENTAL
Intervention: Only amiodarone (group AMI)
Number of subjects: 21
Study 12559536 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=13)
Number of subjects: 21
Study 10828223 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostar Plus (PVS)
Number of subjects: 60
Study 10828223 — intervention group
Group type: COMPARATOR
Intervention: Conventional manual compression
Number of subjects: 60
Study 9083316 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol, 50 microg every 4 hours up to three doses (n = 76)
Number of subjects: 155
Study 9083316 — intervention group
Group type: COMPARATOR
Intervention: Intracervical dinoprostone gel, 0.5 mg every 6 hours up to three doses (n = 79)
Number of subjects: 155
Study 8472213 — intervention group
Group type: EXPERIMENTAL
Intervention: He:Ne laser treatment
Number of subjects: 19
Study 8472213 — intervention group
Group type: EXPERIMENTAL
Intervention: He:Ne + Nd:YAG laser treatment
Number of subjects: 19
Study 2992300 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone administration
Number of subjects: 4
Study 2992300 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 30873586 — intervention group
Group type: EXPERIMENTAL
Intervention: Ego depletion manipulations
Number of subjects: 0
Study 30996056 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 667
Study 30996056 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg
Number of subjects: 667
Study 30996056 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 667
Study 27753111 — intervention group
Group type: EXPERIMENTAL
Intervention: HyFoSy (foam instillation)
Number of subjects: 37
Study 27753111 — intervention group
Group type: COMPARATOR
Intervention: HyCoSy (saline solution)
Number of subjects: 37
Study 25452017 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilization treatment
Number of subjects: 33
Study 25452017 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement system impairment-based treatment
Number of subjects: 33
Study 25452017 — intervention group
Group type: COMPARATOR
Intervention: Control group (subjects without LBP)
Number of subjects: 33
Study 23356115 — intervention group
Group type: EXPERIMENTAL
Intervention: CRIC device
Number of subjects: 20
Study 23356115 — intervention group
Group type: COMPARATOR
Intervention: Standard surgical method
Number of subjects: 20
Study 21493422 — intervention group
Group type: EXPERIMENTAL
Intervention: Pillar implants
Number of subjects: 51
Study 21493422 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 51
Study 19660037 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical debridement
Number of subjects: 676
Study 19660037 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent debridement
Number of subjects: 676
Study 19660037 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial debridement in DFUs
Number of subjects: 676
Study 19660037 — intervention group
Group type: COMPARATOR
Intervention: No surgical debridement
Number of subjects: 676
Study 16918655 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric heat and moisture exchange filter (HMEF)
Number of subjects: 10
Study 15806263 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral arciform incision
Number of subjects: 20
Study 15806263 — intervention group
Group type: COMPARATOR
Intervention: Supra-umbilical midline incision
Number of subjects: 20
Study 15806263 — intervention group
Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 20
Study 11371405 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary edema fluid from patients with ALI/ARDS
Number of subjects: 0
Study 11371405 — intervention group
Group type: COMPARATOR
Intervention: Pooled plasma from healthy donors
Number of subjects: 0
Study 11371405 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-1 receptor antagonist
Number of subjects: 0
Study 9296429 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 60% lidocaine tape (Group B)
Number of subjects: 90
Study 9296429 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine mixed with propofol (Group C)
Number of subjects: 90
Study 9296429 — intervention group
Group type: COMPARATOR
Intervention: Bioocclusive dressing with propofol (Group A)
Number of subjects: 90
Study 8359191 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocloprost 5 micrograms i.v.
Number of subjects: 10
Study 8359191 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocloprost 100, 200, and 400 micrograms p.o.
Number of subjects: 10
Study 3535752 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-2 interferon (2 X 10(6) IU, three times each week for up to 52 weeks)
Number of subjects: 98
Study 3535752 — intervention group
Group type: COMPARATOR
Intervention: placebo (three times each week for up to 52 weeks)
Number of subjects: 98
Study 3535752 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-2 interferon
Number of subjects: 98
Study 3535752 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 98
Study 31505892 — intervention group
Group type: EXPERIMENTAL
Intervention: PM education group (pattern management education using continuous glucose monitoring system results)
Number of subjects: 0
Study 31505892 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional diabetes education)
Number of subjects: 0
Study 29972942 — intervention group
Group type: EXPERIMENTAL
Intervention: Graft group
Number of subjects: 30
Study 29972942 — intervention group
Group type: COMPARATOR
Intervention: Non-graft group
Number of subjects: 30
Study 26664107 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD cases identified by spirometry
Number of subjects: 5463
Study 26664107 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (controls)
Number of subjects: 5463
Study 26664107 — intervention group
Group type: EXPERIMENTAL
Intervention: Univariate logistic regression analysis
Number of subjects: 5463
Study 26664107 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate logistic regression model
Number of subjects: 5463
Study 26664107 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective factors identified
Number of subjects: 5463
Study 23683374 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training + diet (RT+diet); n=4
Number of subjects: 7
Study 23683374 — intervention group
Group type: COMPARATOR
Intervention: Diet control; n=3
Number of subjects: 7
Study 22011335 — intervention group
Group type: EXPERIMENTAL
Intervention: Swaymeter
Number of subjects: 40
Study 19926008 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine, Lisinopril, Doxazosin
Number of subjects: 423
Study 19926008 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 423
Study 19926008 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline AF/AFL
Number of subjects: 423
Study 19926008 — intervention group
Group type: EXPERIMENTAL
Intervention: AF/AFL presence at baseline or during trial
Number of subjects: 423
Study 17166343 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 0
Study 17166343 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 0
Study 17166343 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 0
Study 14719298 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment using the eight methods of intelligent turtle (Ling Gui Ba Fa)
Number of subjects: 0
Study 14719298 — intervention group
Group type: COMPARATOR
Intervention: Control group treated with points selected according to syndrome-differentiation
Number of subjects: 0
Study 10802401 — intervention group
Group type: COMPARATOR
Intervention: Alora placebo patch
Number of subjects: 99
Study 8880096 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil (2 mg)
Number of subjects: 10
Study 8880096 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 10
Study 2000035 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg/kg body weight (BW) protein meal
Number of subjects: 8
Study 2000035 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg/kg BW protein meal
Number of subjects: 8
Study 2000035 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g/kg BW protein meal
Number of subjects: 8
Study 2000035 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g/kg BW protein meal
Number of subjects: 8
Study 2000035 — intervention group
Group type: EXPERIMENTAL
Intervention: All protein meals
Number of subjects: 8
Study 2000035 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg/kg BW protein meal
Number of subjects: 8
Study 6408500 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 70
Study 6408500 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin
Number of subjects: 70
Study 31002434 — intervention group
Group type: EXPERIMENTAL
Intervention: mAFA-integrated care intervention
Number of subjects: 3660
Study 31002434 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3660
Study 29215514 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol with transcervical Foley bulb
Number of subjects: 200
Study 29215514 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol alone
Number of subjects: 200
Study 27111273 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolysed whey formula containing oligosaccharides (0.8 g/100 ml) (pHF‐OS)
Number of subjects: 863
Study 27111273 — intervention group
Group type: COMPARATOR
Intervention: Standard cow's milk formula (control)
Number of subjects: 863
Study 27111273 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolysed whey formula containing oligosaccharides (pHF‐OS)
Number of subjects: 863
Study 25482837 — intervention group
Group type: EXPERIMENTAL
Intervention: risperidone
Number of subjects: 600
Study 25482837 — intervention group
Group type: EXPERIMENTAL
Intervention: aripiprazole
Number of subjects: 600
Study 25482837 — intervention group
Group type: EXPERIMENTAL
Intervention: olanzapine
Number of subjects: 600
Study 22252800 — intervention group
Group type: EXPERIMENTAL
Intervention: Primaquine plus chloroquine (3 days)
Number of subjects: 393
Study 22252800 — intervention group
Group type: EXPERIMENTAL
Intervention: Primaquine plus artesunate (7 days)
Number of subjects: 393
Study 21375020 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture group
Number of subjects: 92
Study 21375020 — intervention group
Group type: COMPARATOR
Intervention: Medication group
Number of subjects: 92
Study 18062596 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgery (microdiscectomy after a mean of 2.2 weeks)
Number of subjects: 283
Study 18062596 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (prolonged conservative treatment with later surgery if necessary)
Number of subjects: 283